600993 Mayinglong Pharmaceutical Group
- 23.74
- -0.32-1.33%
Mayinglong Pharmaceutical Group News
Mayinglong Pharmaceutical Group's announcement on the extension of the duration of the industrial investment fund.
Announcement from Mayinglong Pharmaceutical Group regarding its wholly-owned subsidiary obtaining a pharmaceutical registration certificate.
Announcement from Mayinglong Pharmaceutical Group regarding its wholly-owned subsidiary obtaining a pharmaceutical registration certificate.
Mayinglong Pharmaceutical Group's Annual Shareholders' Meeting Legal Opinion Letter for 2023.
Mayinglong Pharmaceutical Group's announcement of the resolution of the 2023 Annual Shareholders Meeting.
Mayinglong Pharmaceutical Group's 2023 Annual Shareholders Meeting materials.
Announcement on Shareholder Renaming by Mayinglong Pharmaceutical Group
Ma Yinglong's announcement on convening the 2023 Annual General Meeting of Shareholders
Ma Yinglong\'s 2023 Internal Control Evaluation Report
Ma Yinglong\'s 2023 Audit Committee Work Report
Report on Ma Yinglong\'s Board of Directors Audit Committee\'s performance of supervisory duties on accounting firms
Ma Yinglong\'s announcement on the use of idle funds to entrust financial management credits
Ma Yinglong Board Nomination Committee Rules
Ma Yinglong Board Audit Committee Rules of Procedure
Ma Yinglong Board Remuneration and Assessment Committee Rules
Ma Yinglong Board Strategy Committee Rules of Procedure
Independent Director Ma Yinglong\'s Independent Opinions on the Company\'s Appointment of Senior Executives
Announcement of Resolutions of Ma Yinglong\'s 2022 Annual General Meeting of Shareholders
Ma Yinglong\'s announcement on the adjustment of members of the Special Committee
Ma Yinglong\'s 2022 Annual General Meeting of Shareholders Legal Opinion
Analysis
Price Target
No Data
